Show newer

@jeffjarvis Hendryks is a newly minted PhD who is a co-director of the Center for AI Safety. The other director is an undergraduate Stanford student. Can't believe anyone would take this seriously.

@ct_bergstrom Went down the rabbit hole on this after I saw the answer and found this article with a nice photo of Venus that really illustrates the effect. skyatnightmagazine.com/astroph

@jeffjarvis Kind of ironic that ChatGPT is advertising a $200K paralegal job - one of the jobs allegedly threatened by LLMs. openai.com/careers/litigation-

@glennf Pretty clear that Manjoo, who apparently was a hobbyist coder many years ago, doesn't really understand what a professional software developer does for a living. Hint: there's a lot more to it than spitting out syntactically correct code snippets that are functionally correct perhaps 70-80% of the time.

@ct_bergstrom How is this different than *any* kind of programming error that might kill people like, you know, software on a 737 Max?

This looks like a badly programmed RL reward function. WTF?

@ct_bergstrom I guess "AI-Controlled Drone Goes Rogue, Kills Human Operator in USAF video game" didn't get enough clicks in the A/B test.

Joe boosted

Its like a coordinated DDOS PR attack from these existential risk people and they're succeeding in making me constantly talk about them.

NY Times has unabashedly converted to full tabloid mode now.

Joe boosted

@ct_bergstrom Give me chastity and continence, but not yet!

Joe boosted

This scenario is why Daniel Dennett is right theatlantic.com/technology/arc to say that the act of counterfeiting people is the great danger and that it should be illegal. Do whatever else you want with your AI; you should not be allowed to create fake humans for purposes of deception. infosec.exchange/@jerry/110402

Joe boosted

Just tried to find the formula for a rotation matrix in n-dimensional space and ChatGPT, Bard, and Bing all gave me the wrong answer.

Joe boosted

Long-sought universal #flu #vaccine: #mRNA-based candidate enters #clinicaltrial
An mRNA-based flu vaccine designed to offer long-lasting protection against a broad range of #influenza viruses is now in a phase I clinical trial, #NIH announced. The phase I trial will test safety and efficacy in a small number of people. arstechnica.com/health/2023/05

@inthehands @kendraserra Such an old theme in technology. COBOL, "visual programming" etc. all marketed as programming for non-technical folks..

@paulgowder And wondering what the law might have to say about possible OpenAI liability despite their TOS.

Show older
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.